Concepts (282)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 34 | 2024 | 658 | 6.300 |
Why?
|
| Neuropsychological Tests | 40 | 2024 | 890 | 4.300 |
Why?
|
| Dementia | 12 | 2024 | 441 | 2.960 |
Why?
|
| Deep Brain Stimulation | 13 | 2021 | 382 | 2.890 |
Why?
|
| Cultural Competency | 5 | 2023 | 52 | 2.840 |
Why?
|
| Cognitive Dysfunction | 9 | 2023 | 219 | 2.690 |
Why?
|
| Cognition Disorders | 9 | 2011 | 542 | 1.300 |
Why?
|
| Language | 8 | 2023 | 198 | 1.100 |
Why?
|
| Alzheimer Disease | 3 | 2021 | 753 | 0.930 |
Why?
|
| Memory | 6 | 2023 | 355 | 0.920 |
Why?
|
| Amyotrophic Lateral Sclerosis | 7 | 2018 | 135 | 0.910 |
Why?
|
| Pallidotomy | 3 | 2008 | 11 | 0.910 |
Why?
|
| Verbal Behavior | 4 | 2010 | 50 | 0.840 |
Why?
|
| Globus Pallidus | 7 | 2014 | 62 | 0.840 |
Why?
|
| Memory Disorders | 7 | 2020 | 230 | 0.830 |
Why?
|
| Neuropsychology | 2 | 2023 | 23 | 0.810 |
Why?
|
| Movement Disorders | 2 | 2021 | 221 | 0.780 |
Why?
|
| Subthalamic Nucleus | 4 | 2021 | 56 | 0.750 |
Why?
|
| Aged | 42 | 2024 | 18432 | 0.750 |
Why?
|
| Cues | 2 | 2019 | 88 | 0.740 |
Why?
|
| Semantics | 2 | 2019 | 18 | 0.710 |
Why?
|
| Neurosurgery | 1 | 2021 | 77 | 0.710 |
Why?
|
| Language Tests | 1 | 2019 | 24 | 0.660 |
Why?
|
| Temporal Lobe | 3 | 2010 | 113 | 0.610 |
Why?
|
| Quality of Life | 7 | 2024 | 1893 | 0.600 |
Why?
|
| Cognition | 9 | 2022 | 715 | 0.590 |
Why?
|
| Humans | 75 | 2024 | 121122 | 0.550 |
Why?
|
| Verbal Learning | 4 | 2011 | 63 | 0.500 |
Why?
|
| Disease Progression | 8 | 2024 | 1968 | 0.500 |
Why?
|
| Pandemics | 3 | 2021 | 1093 | 0.490 |
Why?
|
| Functional Laterality | 9 | 2009 | 174 | 0.450 |
Why?
|
| Middle Aged | 34 | 2024 | 25297 | 0.440 |
Why?
|
| Depression | 5 | 2021 | 1196 | 0.440 |
Why?
|
| Postoperative Complications | 6 | 2009 | 2871 | 0.430 |
Why?
|
| Pilot Projects | 5 | 2020 | 1355 | 0.400 |
Why?
|
| Speech Disorders | 1 | 2012 | 41 | 0.400 |
Why?
|
| Telemedicine | 4 | 2021 | 418 | 0.400 |
Why?
|
| Male | 44 | 2024 | 58941 | 0.390 |
Why?
|
| Female | 45 | 2024 | 64043 | 0.380 |
Why?
|
| Mental Recall | 1 | 2011 | 137 | 0.360 |
Why?
|
| Speech Articulation Tests | 1 | 2010 | 8 | 0.360 |
Why?
|
| Mental Processes | 3 | 2011 | 41 | 0.340 |
Why?
|
| Frontal Lobe | 1 | 2010 | 101 | 0.340 |
Why?
|
| Activities of Daily Living | 6 | 2022 | 390 | 0.340 |
Why?
|
| Movement | 1 | 2007 | 163 | 0.260 |
Why?
|
| Aged, 80 and over | 13 | 2022 | 6095 | 0.250 |
Why?
|
| Forecasting | 3 | 2023 | 349 | 0.250 |
Why?
|
| Brain | 4 | 2016 | 2918 | 0.240 |
Why?
|
| Depressive Disorder | 1 | 2008 | 450 | 0.230 |
Why?
|
| Anterior Temporal Lobectomy | 3 | 2009 | 10 | 0.230 |
Why?
|
| Parkinsonian Disorders | 2 | 2018 | 74 | 0.230 |
Why?
|
| Occupational Therapy | 1 | 2024 | 36 | 0.220 |
Why?
|
| Translations | 1 | 2023 | 16 | 0.220 |
Why?
|
| Mood Disorders | 2 | 2018 | 123 | 0.220 |
Why?
|
| Republic of Korea | 1 | 2023 | 37 | 0.220 |
Why?
|
| Vietnam | 1 | 2023 | 43 | 0.220 |
Why?
|
| Translating | 1 | 2023 | 31 | 0.220 |
Why?
|
| Multimorbidity | 1 | 2023 | 18 | 0.220 |
Why?
|
| Treatment Outcome | 12 | 2017 | 11690 | 0.210 |
Why?
|
| Surveys and Questionnaires | 4 | 2023 | 3599 | 0.210 |
Why?
|
| Motivation | 2 | 2018 | 307 | 0.210 |
Why?
|
| Culturally Competent Care | 1 | 2023 | 45 | 0.210 |
Why?
|
| Disabled Persons | 1 | 2024 | 98 | 0.210 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2003 | 84 | 0.200 |
Why?
|
| Quarantine | 1 | 2021 | 17 | 0.200 |
Why?
|
| Implantable Neurostimulators | 1 | 2021 | 16 | 0.200 |
Why?
|
| Walking Speed | 1 | 2021 | 15 | 0.190 |
Why?
|
| Feasibility Studies | 3 | 2022 | 721 | 0.190 |
Why?
|
| Cohort Studies | 5 | 2024 | 4603 | 0.190 |
Why?
|
| HIV Seropositivity | 1 | 2001 | 113 | 0.180 |
Why?
|
| Preoperative Care | 2 | 2021 | 348 | 0.180 |
Why?
|
| Psychomotor Performance | 3 | 2014 | 188 | 0.180 |
Why?
|
| United States | 8 | 2023 | 10347 | 0.180 |
Why?
|
| Analysis of Variance | 5 | 2018 | 993 | 0.180 |
Why?
|
| Behavioral Symptoms | 1 | 2020 | 26 | 0.170 |
Why?
|
| Frontotemporal Dementia | 2 | 2010 | 37 | 0.170 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 116 | 0.170 |
Why?
|
| Wearable Electronic Devices | 1 | 2021 | 101 | 0.170 |
Why?
|
| Gait | 2 | 2021 | 143 | 0.170 |
Why?
|
| Postoperative Care | 1 | 2021 | 294 | 0.170 |
Why?
|
| Visual Perception | 2 | 2011 | 123 | 0.160 |
Why?
|
| Frailty | 1 | 2021 | 97 | 0.160 |
Why?
|
| Electrodes, Implanted | 2 | 2009 | 151 | 0.150 |
Why?
|
| Stereotypic Movement Disorder | 1 | 2018 | 13 | 0.150 |
Why?
|
| Emotions | 2 | 2011 | 362 | 0.150 |
Why?
|
| Restless Legs Syndrome | 1 | 2018 | 19 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2023 | 1870 | 0.150 |
Why?
|
| Follow-Up Studies | 7 | 2014 | 4966 | 0.150 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 1264 | 0.140 |
Why?
|
| Hippocampus | 1 | 2003 | 802 | 0.140 |
Why?
|
| Anxiety | 2 | 2015 | 943 | 0.140 |
Why?
|
| Executive Function | 3 | 2014 | 97 | 0.140 |
Why?
|
| Genetic Testing | 1 | 2023 | 989 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2019 | 367 | 0.130 |
Why?
|
| Irritants | 1 | 1995 | 7 | 0.130 |
Why?
|
| Erythema | 1 | 1995 | 24 | 0.130 |
Why?
|
| Prospective Studies | 4 | 2024 | 5858 | 0.130 |
Why?
|
| Exercise | 2 | 2022 | 785 | 0.120 |
Why?
|
| Retrospective Studies | 7 | 2021 | 15593 | 0.120 |
Why?
|
| Neurocognitive Disorders | 1 | 2015 | 66 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2013 | 3402 | 0.120 |
Why?
|
| Adult | 15 | 2020 | 28389 | 0.120 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 295 | 0.120 |
Why?
|
| Edema | 1 | 1995 | 134 | 0.120 |
Why?
|
| Exercise Therapy | 3 | 2022 | 141 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2018 | 540 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 2787 | 0.110 |
Why?
|
| Educational Status | 2 | 2012 | 258 | 0.110 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2014 | 32 | 0.110 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 473 | 0.110 |
Why?
|
| Compulsive Behavior | 1 | 2014 | 40 | 0.110 |
Why?
|
| Medication Adherence | 2 | 2015 | 383 | 0.110 |
Why?
|
| Life Style | 1 | 2016 | 390 | 0.110 |
Why?
|
| Aging, Premature | 1 | 2013 | 32 | 0.110 |
Why?
|
| Tetraspanins | 1 | 2013 | 29 | 0.110 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 2780 | 0.110 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 54 | 0.110 |
Why?
|
| Comorbidity | 4 | 2019 | 1472 | 0.110 |
Why?
|
| Motor Activity | 2 | 2011 | 507 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 2 | 2010 | 199 | 0.100 |
Why?
|
| Language Development Disorders | 1 | 2013 | 166 | 0.100 |
Why?
|
| Antiparasitic Agents | 1 | 2012 | 31 | 0.100 |
Why?
|
| Hypotension, Orthostatic | 1 | 2011 | 16 | 0.100 |
Why?
|
| Levodopa | 1 | 2012 | 89 | 0.100 |
Why?
|
| Space Perception | 2 | 2009 | 62 | 0.100 |
Why?
|
| Language Disorders | 2 | 2009 | 22 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2013 | 526 | 0.090 |
Why?
|
| Demography | 1 | 2011 | 236 | 0.090 |
Why?
|
| Patient Admission | 1 | 2012 | 184 | 0.090 |
Why?
|
| Geriatric Assessment | 1 | 2011 | 168 | 0.090 |
Why?
|
| Sneddon Syndrome | 1 | 2010 | 3 | 0.090 |
Why?
|
| Reference Values | 1 | 2011 | 694 | 0.090 |
Why?
|
| Behavior | 1 | 2010 | 75 | 0.090 |
Why?
|
| Automation | 1 | 2010 | 58 | 0.090 |
Why?
|
| Apolipoproteins E | 1 | 2010 | 188 | 0.090 |
Why?
|
| Dominance, Cerebral | 1 | 2009 | 50 | 0.080 |
Why?
|
| Age of Onset | 4 | 2013 | 563 | 0.080 |
Why?
|
| Residence Characteristics | 1 | 2011 | 260 | 0.080 |
Why?
|
| Aging | 1 | 2016 | 1154 | 0.080 |
Why?
|
| Specialization | 1 | 2010 | 75 | 0.080 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2009 | 5 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2010 | 385 | 0.080 |
Why?
|
| Spinal Puncture | 1 | 2009 | 53 | 0.080 |
Why?
|
| Chorea | 1 | 2009 | 38 | 0.080 |
Why?
|
| Base Sequence | 1 | 2013 | 3104 | 0.080 |
Why?
|
| Disability Evaluation | 1 | 2009 | 181 | 0.080 |
Why?
|
| Stereotaxic Techniques | 2 | 1999 | 71 | 0.080 |
Why?
|
| Memory, Short-Term | 1 | 2009 | 132 | 0.080 |
Why?
|
| Survival Rate | 2 | 2010 | 1981 | 0.080 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 422 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2015 | 3203 | 0.070 |
Why?
|
| Reaction Time | 1 | 2008 | 167 | 0.070 |
Why?
|
| Huntington Disease | 1 | 2009 | 140 | 0.070 |
Why?
|
| Neurologic Examination | 1 | 2008 | 193 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 558 | 0.070 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2006 | 13 | 0.070 |
Why?
|
| Unemployment | 1 | 2006 | 19 | 0.070 |
Why?
|
| Ambulatory Care | 1 | 2010 | 376 | 0.070 |
Why?
|
| Patch Tests | 2 | 1997 | 6 | 0.070 |
Why?
|
| Affective Symptoms | 1 | 2006 | 58 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 372 | 0.070 |
Why?
|
| Prevalence | 3 | 2020 | 2352 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 645 | 0.070 |
Why?
|
| Software | 1 | 2010 | 669 | 0.060 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2024 | 17 | 0.060 |
Why?
|
| Time Factors | 3 | 2008 | 5976 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2010 | 1451 | 0.060 |
Why?
|
| Speech Therapy | 1 | 2024 | 7 | 0.060 |
Why?
|
| Reoperation | 1 | 2007 | 772 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 799 | 0.060 |
Why?
|
| Reward | 1 | 2004 | 105 | 0.060 |
Why?
|
| HIV Infections | 1 | 2015 | 1859 | 0.050 |
Why?
|
| Hospitalization | 1 | 2012 | 1717 | 0.050 |
Why?
|
| Taiwan | 1 | 2023 | 31 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 63 | 0.050 |
Why?
|
| Sclerosis | 1 | 2003 | 28 | 0.050 |
Why?
|
| Vocabulary | 1 | 2003 | 23 | 0.050 |
Why?
|
| Brazil | 1 | 2023 | 112 | 0.050 |
Why?
|
| Phonetics | 1 | 2003 | 40 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2018 | 744 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 3066 | 0.050 |
Why?
|
| China | 1 | 2023 | 223 | 0.050 |
Why?
|
| Neurosurgeons | 1 | 2021 | 11 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2003 | 330 | 0.050 |
Why?
|
| Neurologists | 1 | 2021 | 17 | 0.050 |
Why?
|
| CD4 Antigens | 1 | 2001 | 57 | 0.050 |
Why?
|
| Veterans | 2 | 2012 | 1687 | 0.050 |
Why?
|
| Speech Perception | 1 | 2001 | 48 | 0.050 |
Why?
|
| Canada | 1 | 2021 | 291 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2021 | 280 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 148 | 0.040 |
Why?
|
| Thalamic Nuclei | 1 | 1999 | 16 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 1199 | 0.040 |
Why?
|
| Motor Skills | 1 | 1999 | 84 | 0.040 |
Why?
|
| Walking | 1 | 2021 | 197 | 0.040 |
Why?
|
| Affect | 1 | 1999 | 154 | 0.040 |
Why?
|
| Social Class | 1 | 2019 | 173 | 0.040 |
Why?
|
| Attention | 2 | 2010 | 193 | 0.040 |
Why?
|
| Hospitals, Veterans | 2 | 2012 | 353 | 0.040 |
Why?
|
| Risk Factors | 2 | 2024 | 9617 | 0.040 |
Why?
|
| Caregivers | 1 | 2022 | 552 | 0.040 |
Why?
|
| Acute Disease | 1 | 2019 | 1086 | 0.030 |
Why?
|
| Patient Selection | 1 | 1999 | 645 | 0.030 |
Why?
|
| Time | 1 | 2016 | 90 | 0.030 |
Why?
|
| Cetrimonium Compounds | 1 | 1995 | 3 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1995 | 15 | 0.030 |
Why?
|
| Sodium Hydroxide | 1 | 1995 | 7 | 0.030 |
Why?
|
| Acetic Acid | 1 | 1995 | 18 | 0.030 |
Why?
|
| Cyclohexenes | 1 | 1995 | 11 | 0.030 |
Why?
|
| Ethanolamines | 1 | 1995 | 29 | 0.030 |
Why?
|
| Terpenes | 1 | 1995 | 28 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 402 | 0.030 |
Why?
|
| Acetates | 1 | 1995 | 72 | 0.030 |
Why?
|
| Self Report | 1 | 2018 | 485 | 0.030 |
Why?
|
| Telephone | 1 | 2015 | 109 | 0.030 |
Why?
|
| Postural Balance | 1 | 2016 | 125 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1139 | 0.030 |
Why?
|
| Allergens | 1 | 1997 | 242 | 0.030 |
Why?
|
| Logistic Models | 2 | 2009 | 1741 | 0.030 |
Why?
|
| Adolescent | 3 | 2006 | 18761 | 0.030 |
Why?
|
| Neurons | 1 | 2004 | 1914 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2015 | 444 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 259 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2013 | 111 | 0.030 |
Why?
|
| Health Surveys | 1 | 2014 | 231 | 0.030 |
Why?
|
| Databases, Bibliographic | 1 | 2012 | 20 | 0.030 |
Why?
|
| Biomarkers | 1 | 2021 | 2917 | 0.020 |
Why?
|
| Pharmaceutical Services | 1 | 2012 | 35 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 412 | 0.020 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2012 | 164 | 0.020 |
Why?
|
| Exons | 1 | 2013 | 793 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 253 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2010 | 101 | 0.020 |
Why?
|
| Medication Errors | 1 | 2012 | 184 | 0.020 |
Why?
|
| Pedigree | 1 | 2013 | 1572 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 130 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2010 | 164 | 0.020 |
Why?
|
| Pattern Recognition, Visual | 1 | 2009 | 23 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 3267 | 0.020 |
Why?
|
| Geriatrics | 1 | 2010 | 71 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 1231 | 0.020 |
Why?
|
| Pharmacy Service, Hospital | 1 | 1989 | 49 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 837 | 0.020 |
Why?
|
| Skin Diseases | 1 | 2010 | 120 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 138 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 190 | 0.020 |
Why?
|
| Child | 2 | 2013 | 23984 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2010 | 172 | 0.020 |
Why?
|
| Neurology | 1 | 2010 | 108 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3855 | 0.020 |
Why?
|
| Outpatients | 1 | 2010 | 253 | 0.020 |
Why?
|
| Face | 1 | 2009 | 181 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 267 | 0.020 |
Why?
|
| Body Composition | 1 | 2010 | 472 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 1749 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 568 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1586 | 0.020 |
Why?
|
| Learning | 1 | 2010 | 357 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 1989 | 265 | 0.020 |
Why?
|
| Psychiatry | 1 | 2010 | 263 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 1215 | 0.020 |
Why?
|
| Young Adult | 2 | 2010 | 8645 | 0.020 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2009 | 642 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 1998 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 2530 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 569 | 0.010 |
Why?
|
| Seizures | 1 | 2008 | 872 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 798 | 0.010 |
Why?
|
| Motor Skills Disorders | 1 | 2000 | 9 | 0.010 |
Why?
|
| Obesity | 1 | 2010 | 2083 | 0.010 |
Why?
|
| Microelectrodes | 1 | 1998 | 39 | 0.010 |
Why?
|
| Hemiplegia | 1 | 1998 | 40 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 13733 | 0.010 |
Why?
|
| Algorithms | 1 | 2004 | 1568 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1998 | 140 | 0.010 |
Why?
|
| Reference Standards | 1 | 1997 | 240 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1989 | 15 | 0.010 |
Why?
|
| San Francisco | 1 | 1989 | 17 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1989 | 162 | 0.010 |
Why?
|
| Medical Records | 1 | 1989 | 189 | 0.000 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1989 | 792 | 0.000 |
Why?
|
| Animals | 1 | 2004 | 33423 | 0.000 |
Why?
|